This company has been marked as potentially delisted and may not be actively trading. Adamis Pharmaceuticals (ADMP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Quantum Computing (NASDAQ:QUBT) Stock Quotes, Forecast and News SummaryNovember 15, 2024 | benzinga.comDMK Pharmaceuticals Corp DMKNovember 8, 2023 | morningstar.comAdamis changes name to DMK Pharmaceuticals, ticker to DMKSeptember 7, 2023 | msn.comAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusSeptember 7, 2023 | finance.yahoo.comAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 21, 2023 | finanznachrichten.deAdamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 21, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingAugust 4, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingAugust 2, 2023 | finance.yahoo.comTrading was temporarily halted for "ADMP" at 11:08 AM with a stated reason of "LULD pause." Trading set to resume at 11:08 AM. August 2, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 11:08 AM with a stated reason of "LULD pause."August 2, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 11:08 AM with a stated reason of "LULD pause."August 2, 2023 | marketbeat.comAdamis Pharmaceuticals Stock Soars To More Than Double - What's Going On?August 1, 2023 | msn.comAdamis stock soars as high as 480% amid asset sale, drug study newsAugust 1, 2023 | msn.comTrading was temporarily halted for "ADMP" at 12:08 PM with a stated reason of "LULD pause." Trading set to resume at 12:08 PM. August 1, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 10:08 AM with a stated reason of "LULD pause."August 1, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 10:08 AM with a stated reason of "LULD pause."August 1, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 10:08 AM with a stated reason of "LULD pause."August 1, 2023 | marketbeat.comTrading was temporarily halted for "ADMP" at 09:08 AM with a stated reason of "LULD pause."August 1, 2023 | marketbeat.comAdamis Pharma to Fund Clinical Study with University of Leiden Opioid ExpertJuly 28, 2023 | marketwatch.comAdamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertJuly 28, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces NIH Grant Funding For Treatment Of Alcohol Use Disorder, Size Not DisclosedJune 26, 2023 | benzinga.comAdamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderJune 26, 2023 | finance.yahoo.comAdamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionJune 22, 2023 | finance.yahoo.comAdamis Pharmaceuticals (NASDAQ: ADMP)June 4, 2023 | fool.comAdamis Pharmaceuticals CEO Awarded $210K Worth of Stock OptionsMay 31, 2023 | benzinga.comBoard Member at Adamis Pharmaceuticals Acquires Company Stock Options Worth 25,720 SharesMay 31, 2023 | benzinga.comAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsMay 26, 2023 | finanznachrichten.deAdamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsMay 25, 2023 | finance.yahoo.comTrading was temporarily halted for "ADMP" at 10:05 AM with a stated reason of "LULD pause."May 22, 2023 | marketbeat.comAdamis Pharma slips 19% on plans for reverse stock slipMay 21, 2023 | seekingalpha.comAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Reverse Stock SplitMay 19, 2023 | finanznachrichten.deAdamis Pharmaceuticals Announces Reverse Stock SplitMay 19, 2023 | finance.yahoo.comQ1 2023 Adamis Pharmaceuticals Corp Earnings CallMay 16, 2023 | finance.yahoo.comAdamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 15, 2023 | finance.yahoo.comAdamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate UpdateMay 8, 2023 | finance.yahoo.com8-K: Adamis Pharmaceuticals CorpMay 7, 2023 | marketwatch.comAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q4 2022 Earnings Call TranscriptMarch 19, 2023 | finance.yahoo.comQ4 2022 Adamis Pharmaceuticals Corp Earnings CallMarch 17, 2023 | finance.yahoo.comAdamis Pharmaceuticals GAAP EPS of -$0.18, revenue of $4.75MMarch 16, 2023 | msn.comAdamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 16, 2023 | finance.yahoo.comAdamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate UpdateMarch 14, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces $3.0 Million Registered Direct OfferingMarch 14, 2023 | finance.yahoo.comShort Volatility Alert: Adamis PharmaceuticalsMarch 2, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Adamis Pharmaceuticals Corporation MergerMarch 1, 2023 | benzinga.comOpioid Focused Adamis Pharma Agrees To Merge With Privately Held DMK PharmaceuticalsFebruary 28, 2023 | msn.comAdamis Pharmaceuticals jumps 36% on DMK Pharmaceuticals merger planFebruary 28, 2023 | msn.comAdamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of MergerFebruary 27, 2023 | finance.yahoo.comTrading was temporarily halted for "ADMP" at 04:02 PM with a stated reason of "News pending."February 27, 2023 | marketbeat.comNasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing RequirementsFebruary 22, 2023 | finance.yahoo.comAdamis Pharmaceuticals Corporation (NASDAQ:ADMP) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | finance.yahoo.com Get Adamis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMP and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMP Media Mentions By Week ADMP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMP News Sentiment▼0.000.72▲Average Medical News Sentiment ADMP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMP Articles This Week▼00▲ADMP Articles Average Week Get Adamis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sunshine Biopharma News Today Greater Cannabis News Today Scilex News Today PolyPid News Today VYNE Therapeutics News Today Generation Bio News Today Tempest Therapeutics News Today Daré Bioscience News Today Clene News Today NeuroOne Medical Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMP) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adamis Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adamis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
